FDA clears Teleflex’s Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter

Teleflex Incorporated (NYSE:TFX) announced today the Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The Arrow FlexTip Plus, the market-leading Open Tip, Single-Port epidural catheter, has been proven to significantly reduce complications commonly associated with epidural catheters, such as vein cannulations and paresthesia. The Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter has been designed using the same proven technology of the Open Tip, Single-Port catheter, the only coil-reinforced catheter backed by more than a decade of clinical evidence. With the addition of the Closed Tip, Multi-Port catheter, FlexTip Plus now provides the drug dispersion choices clinicians demand.

The coil-reinforced FlexTip Plus catheter material is constructed of polyurethane, while a majority of spring wound catheters are made of nylon. This provides a unique balance of softness and strength which promotes easier insertion, less movement out of the epidural space, better block quality, and higher satisfaction rates. The Closed Tip, Multi-Port catheter provides excellent kink resistance and features a soft, flexible tip with 4 lateral holes.

"Teleflex is adding the FlexTip Plus Closed Tip, Multi-Port to the Arrow catheter family to continue to support physicians with products that address the concerns anesthesiologists face on a daily basis," said Cary Vance, President, Teleflex Anesthesia and Respiratory. "The FlexTip Plus Closed Tip, Multi-Port is based on proven technology, helping anesthesiologists achieve the drug dispersion they prefer with the quality of care they demand for their patients."